Hereby, it is of note that genetic variation in HLA-DPA1/DPB1 is associated with PAH [31], suggesting that interactions of CD4+ T cells with HLA class II-expressing cells, including monocytes, DCs or alveolar epithelial cells, may contribute to PAH development. Here, CD4 is linked to pulmonary arterial hypertension.